Krystal Biotech Management

Management criteria checks 3/4

Krystal Biotech's CEO is Krish Krishnan, appointed in Dec 2015, has a tenure of 8.42 years. total yearly compensation is $6.22M, comprised of 11.8% salary and 88.2% bonuses, including company stock and options. directly owns 5.65% of the company’s shares, worth €240.77M. The average tenure of the management team and the board of directors is 2.3 years and 5.9 years respectively.

Key information

Krish Krishnan

Chief executive officer

US$6.2m

Total compensation

CEO salary percentage11.8%
CEO tenure8.4yrs
CEO ownership5.7%
Management average tenure2.3yrs
Board average tenure5.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Krish Krishnan's remuneration changed compared to Krystal Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$6mUS$733k

US$11m

Sep 30 2023n/an/a

-US$30m

Jun 30 2023n/an/a

-US$140m

Mar 31 2023n/an/a

-US$135m

Dec 31 2022US$3mUS$645k

-US$140m

Sep 30 2022n/an/a

-US$130m

Jun 30 2022n/an/a

-US$115m

Mar 31 2022n/an/a

-US$104m

Dec 31 2021US$7mUS$581k

-US$70m

Sep 30 2021n/an/a

-US$58m

Jun 30 2021n/an/a

-US$52m

Mar 31 2021n/an/a

-US$43m

Dec 31 2020US$764kUS$498k

-US$32m

Sep 30 2020n/an/a

-US$27m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$20m

Dec 31 2019US$631kUS$366k

-US$19m

Sep 30 2019n/an/a

-US$17m

Jun 30 2019n/an/a

-US$16m

Mar 31 2019n/an/a

-US$13m

Dec 31 2018US$705kUS$200k

-US$11m

Sep 30 2018n/an/a

-US$9m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$10m

Dec 31 2017US$69kUS$69k

-US$8m

Compensation vs Market: Krish's total compensation ($USD6.22M) is above average for companies of similar size in the German market ($USD2.56M).

Compensation vs Earnings: Krish's compensation has been consistent with company performance over the past year.


CEO

Krish Krishnan (58 yo)

8.4yrs

Tenure

US$6,223,894

Compensation

Mr. Krish S. Krishnan, M.S., M.B.A., is Founder of Krystal Biotech, Inc. since December 2015. He has been President, Chief Executive Officer and Chairman at Krystal Biotech, Inc. since December 2015. Mr. K...


Leadership Team

NamePositionTenureCompensationOwnership
Krish Krishnan
Founder8.4yrsUS$6.22m5.65%
$ 240.8m
Suma Krishnan
Founder8.4yrsUS$3.84m5.75%
$ 245.0m
Kathryn Romano
Executive VP & Chief Accounting Officer4.3yrsUS$2.57m0.045%
$ 1.9m
John Thomas
General Counsel & Corporate Secretaryno datano datano data
John Karakkal
Vice President of North American Sales & Marketingno datano datano data
Christine Wilson
Head of U.S. Sales and Marketingless than a yearno datano data
Josh Suskin
Director of Human Resources & Operationsno datano datano data
Laurent Goux
Senior VP & GM of Europeno datano datano data
David Chien
Senior Vice President of Clinical Development2.3yrsno datano data
Jennifer McDonough
SVP of Patient Accessless than a yearno datano data
Ramesh Arjunji
Senior VP of Global Value and Accessless than a yearno datano data

2.3yrs

Average Tenure

58yo

Average Age

Experienced Management: 4KB's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Krish Krishnan
Founder8.4yrsUS$6.22m5.65%
$ 240.8m
Suma Krishnan
Founder8.3yrsUS$3.84m5.75%
$ 245.0m
Daniel Janney
Lead Independent Director7.5yrsUS$385.86k0.38%
$ 16.0m
Dino Rossi
Independent Director6.9yrsUS$584.82k0.29%
$ 12.5m
Julian Gangolli
Independent Director5.2yrsUS$585.07k0%
$ 0
Christopher Mason
Independent Director3.3yrsUS$568.32k0%
$ 0
Kirti Ganorkar
Non-Employee Independent Director6.7yrsno datano data
Catherine Mazzacco
Independent Director1.2yrsUS$934.43k0%
$ 0
Samuel Broder
Chairman of Scientific Advisory Board4.3yrsno datano data
E. Sutherland
Independent Director2.3yrsUS$570.44k0%
$ 0

5.9yrs

Average Tenure

58yo

Average Age

Experienced Board: 4KB's board of directors are considered experienced (5.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.